AXM Pharma, Inc.
AXMP
$0.0001
$0.000.00%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | 110.68M | 111.88M | 113.08M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 110.68M | 111.88M | 113.08M | -- | -- |
| Cost of Revenue | 89.91M | 91.45M | 93.00M | -- | -- |
| Gross Profit | 20.77M | 20.43M | 20.08M | -- | -- |
| SG&A Expenses | 8.13M | 6.71M | 5.30M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 181.00K | 430.10K | 679.20K | -- | -- |
| Total Operating Expenses | 98.22M | 98.60M | 98.98M | -- | -- |
| Operating Income | 12.46M | 13.28M | 14.11M | -- | -- |
| Income Before Tax | 11.91M | 12.06M | 12.21M | -- | -- |
| Income Tax Expenses | 3.56M | 3.79M | 4.03M | -- | -- |
| Earnings from Continuing Operations | 8.35 | 8.27 | 8.18 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.35M | 8.27M | 8.18M | -- | -- |
| EBIT | 12.46M | 13.28M | 14.11M | -- | -- |
| EBITDA | 10.07M | 6.77M | 3.48M | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -- | -- |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -- | -- |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -- | -- |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -- | -- |
| Average Basic Shares Outstanding | 21.20B | 15.90B | 10.60B | -- | -- |
| Average Diluted Shares Outstanding | 21.20B | 15.90B | 10.60B | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |